Buprenorphine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Buprenorphine. Educational only — not medical advice.

Labeled uses

Buprenorphine sublingual tablets is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support.

Source: FDA labeling via NIH DailyMed (set 442831cf…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.